Dr. Prashant Shukla
Dr. Prashant Shukla
Associate Professor Hygia Institute of pharmaceutical education and research Lucknow
Verified email at hygia.in
Title
Cited by
Cited by
Year
Therapeutic interventions in sepsis: current and anticipated pharmacological agents
P Shukla, GM Rao, G Pandey, S Sharma, N Mittapelly, R Shegokar, ...
British journal of pharmacology 171 (22), 5011-5031, 2014
622014
Development of stabilized paclitaxel nanocrystals: in-vitro and in-vivo efficacy studies
S Sharma, A Verma, BV Teja, P Shukla, PR Mishra
European Journal of Pharmaceutical Sciences 69, 51-60, 2015
512015
Self assembled ionically sodium alginate cross-linked amphotericin B encapsulated glycol chitosan stearate nanoparticles: applicability in better chemotherapy and non-toxic …
PK Gupta, AK Jaiswal, S Asthana, A Verma, V Kumar, P Shukla, ...
Pharmaceutical research 32 (5), 1727-1740, 2015
462015
Optimization of novel tocopheryl acetate nanoemulsions for parenteral delivery of curcumin for therapeutic intervention of sepsis
P Shukla, P Dwivedi, PK Gupta, PR Mishra
Expert opinion on drug delivery 11 (11), 1697-1712, 2014
322014
Preparation, Characterization and Evaluation of Chitosan–Gum Arabic Coacervates as Excipient in Fast Dissolving/Disintegrating Dosage Form
R MALVIYA, P SHUKLA, P SRIVASTAVA, ZA KAPLANCIKLI, ...
FABAD J. Pharm. Sci 34 (1), 13-23, 2009
312009
Chapter 8 - Interfacial and colloidal properties of emulsified systems: Pharmaceutical and biological perspective
S Sharma, P Shukla, A Misra, PR Mishra
Colloid and Interface Science in Pharmaceutical Research and Development …, 2014
282014
Emerging trend in nano-engineered polyelectrolyte-based surrogate carriers for delivery of bioactives
P Shukla, G Gupta, D Singodia, R Shukla, AK Verma, P Dwivedi, S Kansal, ...
Expert Opinion on Drug Delivery 7 (9), 993-1011, 2010
282010
Development and Performance Evaluation of Amphotericin B Transfersomes Against Resistant and Sensitive Clinical Isolates of Visceral Leishmaniasis
D Singodia, GK Gupta, A Verma, V Singh, P Shukla, P Misra, S Sundar, ...
Journal of Biomedical Nanotechnology 6 (3), 293-302, 2010
252010
Exploiting 4-sulphate N-acetyl galactosamine decorated gelatin nanoparticles for effective targeting to professional phagocytes in vitro and in vivo
P Dwivedi, S Kansal, M Sharma, R Shukla, A Verma, P Shukla, P Tripathi, ...
Journal of Drug Targeting, 1-14, 2012
242012
Exploitation of lectinized lipo-polymerosome encapsulated Amphotericin B to target macrophages for effective chemotherapy of visceral leishmaniasis
PK Gupta, S Asthana, AK Jaiswal, V Kumar, AK Verma, P Shukla, ...
Bioconjugate chemistry 25 (6), 1091-1102, 2014
232014
Chitosan coated alginate micro particles for the oral delivery of antifilarial drugs and combinations for intervention in Brugia malayi induced lymphatic filariasis
R Shukla, J Gupta, P Shukla, P Dwivedi, P Tripathi, SM Bhattacharya, ...
RSC advances 5 (85), 69047-69056, 2015
222015
Arteether nanoemulsion for enhanced efficacy against Plasmodium yoelii nigeriensis malaria: An approach by enhanced bioavailability
P Dwivedi, R Khatik, P Chaturvedi, K Khandelwal, I Taneja, KSR Raju, ...
Colloids and Surfaces B: Biointerfaces 126, 467-475, 2015
202015
Factors influencing drug release characteristic from hydrophilic polymer matrix tablet
A Goyal, P Shukla, AK Srivastava
Asian journal of pharmaceutical and clinical research 2 (1), 2009
192009
Nanoemulsion based concomitant delivery of curcumin and etoposide: impact on cross talk between prostate cancer cells and osteoblast during metastasis
P Shukla, V Mathur, A Kumar, V Khedgikar, BV Teja, D Chaudhary, ...
Journal of biomedical nanotechnology 10 (11), 3381-3391, 2014
182014
Self-nanoemulsifying drug delivery systems (SNEDDS) for oral delivery of arteether: pharmacokinetics, toxicity and antimalarial activity in mice
P Dwivedi, R Khatik, K Khandelwal, R Srivastava, I Taneja, KSR Raju, ...
RSC Advances 4 (110), 64905-64918, 2014
182014
Cationic nanoemulsions bearing ciprofloxacin surf-plexes enhances its therapeutic efficacy in conditions of E. coli induced peritonitis and sepsis
V Jain, P Shukla, R Pal, PR Mishra
Pharmaceutical research 31 (10), 2630-2642, 2014
102014
In-Vitro and In-Vivo studies on novel chitosan-g-pluronic F-127 copolymer based nanocarrier of amphotericin B for improved antifungal activity
V Kumar, PK Gupta, VK Pawar, A Verma, R Khatik, P Tripathi, P Shukla, ...
Journal of Biomaterials and Tissue Engineering 4 (3), 210-216, 2014
102014
Moxifloxacin-loaded nanoemulsions having tocopheryl succinate as the integral component improves pharmacokinetics and enhances survival in E. coli-induced complicated intra …
P Shukla, AK Verma, P Dwivedi, A Yadav, PK Gupta, SK Rath, PR Mishra
Molecular pharmaceutics 11 (12), 4314-4326, 2014
92014
Investigations on cellular interaction of polyelectrolyte based nano‐walled reservoir using MCF‐7 cell lines: a novel chemotherapeutic approach
GK Gupta, VK Gupta, P Shukla, AB Pant, PR Mishra
Journal of Pharmacy and Pharmacology 61 (12), 1601-1607, 2009
92009
Development and evaluation of anticancer polymeric nano-formulations containing curcumin and natural bioenhancers
M Dwivedi, S Sharma, P Shukla, PR Mishra, SK Paliwal, AKS Rawat
Journal of Biomaterials and Tissue Engineering 4 (3), 198-202, 2014
82014
The system can't perform the operation now. Try again later.
Articles 1–20